Plasma Fatty Acid Binding Protein 4 and Risk of Sudden Cardiac Death in Older Adults

Although fatty acid binding protein 4 (FABP4) may increase risk of diabetes and exert negative cardiac inotropy, it is unknown whether plasma concentrations of FABP4 are associated with incidence of sudden cardiac death (SCD). We prospectively analyzed data on 4,560 participants of the Cardiovascula...

Full description

Saved in:
Bibliographic Details
Main Authors: Luc Djoussé, Marlena Maziarz, Mary L. Biggs, Joachim H. Ix, Susan J. Zieman, Jorge R. Kizer, Rozenn N. Lemaitre, Dariush Mozaffarian, Russell P. Tracy, Kenneth J. Mukamal, David S. Siscovick, Nona Sotoodehnia
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.1155/2013/181054
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850217366294626304
author Luc Djoussé
Marlena Maziarz
Mary L. Biggs
Joachim H. Ix
Susan J. Zieman
Jorge R. Kizer
Rozenn N. Lemaitre
Dariush Mozaffarian
Russell P. Tracy
Kenneth J. Mukamal
David S. Siscovick
Nona Sotoodehnia
author_facet Luc Djoussé
Marlena Maziarz
Mary L. Biggs
Joachim H. Ix
Susan J. Zieman
Jorge R. Kizer
Rozenn N. Lemaitre
Dariush Mozaffarian
Russell P. Tracy
Kenneth J. Mukamal
David S. Siscovick
Nona Sotoodehnia
author_sort Luc Djoussé
collection DOAJ
description Although fatty acid binding protein 4 (FABP4) may increase risk of diabetes and exert negative cardiac inotropy, it is unknown whether plasma concentrations of FABP4 are associated with incidence of sudden cardiac death (SCD). We prospectively analyzed data on 4,560 participants of the Cardiovascular Health Study. FABP4 was measured at baseline using ELISA, and SCD events were adjudicated through review of medical records. We used Cox proportional hazards to estimate effect measures. During a median followup of 11.8 years, 146 SCD cases occurred. In a multivariable model adjusting for demographic, lifestyle, and metabolic factors, relative risk of SCD associated with each higher standard deviation (SD) of plasma FABP4 was 1.15 (95% CI: 0.95–1.38), P=0.15. In a secondary analysis stratified by prevalent diabetes status, FABP4 was associated with higher risk of SCD in nondiabetic participants, (RR per SD higher FABP4: 1.33 (95% CI: 1.07–1.65), P=0.009) but not in diabetic participants (RR per SD higher FABP4: 0.88 (95% CI: 0.62–1.27), P=0.50), P for diabetes-FABP4 interaction 0.049. In summary, a single measure of plasma FABP4 obtained later in life was not associated with the risk of SCD in older adults overall. Confirmation of our post-hoc results in nondiabetic people in other studies is warranted.
format Article
id doaj-art-3b2510f83da64a0796b2baade446bcfa
institution OA Journals
issn 2090-8016
2090-0597
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Cardiology Research and Practice
spelling doaj-art-3b2510f83da64a0796b2baade446bcfa2025-08-20T02:08:03ZengWileyCardiology Research and Practice2090-80162090-05972013-01-01201310.1155/2013/181054181054Plasma Fatty Acid Binding Protein 4 and Risk of Sudden Cardiac Death in Older AdultsLuc Djoussé0Marlena Maziarz1Mary L. Biggs2Joachim H. Ix3Susan J. Zieman4Jorge R. Kizer5Rozenn N. Lemaitre6Dariush Mozaffarian7Russell P. Tracy8Kenneth J. Mukamal9David S. Siscovick10Nona Sotoodehnia11Division of Aging, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, 1620 Tremont Street, 3rd Floor, Boston, MA 02120, USADepartment of Biostatistics, University of Washington, Seattle, WA 98195, USADepartment of Biostatistics, University of Washington, Seattle, WA 98195, USANephrology Section, Veterans Affairs San Diego Healthcare System, San Diego, CA 92161, USANational Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USACardiology Division, Albert Einstein College of Medicine, New York, NY 10461, USACardiovascular Health Research Unit, Departments of Medicine, University of Washington, Seattle, WA 98195, USADepartment of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02120, USADepartment of Pathology and Biochemistry, University of Vermont College of Medicine, Burlington, VT 05401, USADivision of General Medicine and Primary Care, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02120, USACardiovascular Health Research Unit, Departments of Medicine and Epidemiology, University of Washington, Seattle, WA 98195, USACardiovascular Health Research Unit, Departments of Medicine and Epidemiology, University of Washington, Seattle, WA 98195, USAAlthough fatty acid binding protein 4 (FABP4) may increase risk of diabetes and exert negative cardiac inotropy, it is unknown whether plasma concentrations of FABP4 are associated with incidence of sudden cardiac death (SCD). We prospectively analyzed data on 4,560 participants of the Cardiovascular Health Study. FABP4 was measured at baseline using ELISA, and SCD events were adjudicated through review of medical records. We used Cox proportional hazards to estimate effect measures. During a median followup of 11.8 years, 146 SCD cases occurred. In a multivariable model adjusting for demographic, lifestyle, and metabolic factors, relative risk of SCD associated with each higher standard deviation (SD) of plasma FABP4 was 1.15 (95% CI: 0.95–1.38), P=0.15. In a secondary analysis stratified by prevalent diabetes status, FABP4 was associated with higher risk of SCD in nondiabetic participants, (RR per SD higher FABP4: 1.33 (95% CI: 1.07–1.65), P=0.009) but not in diabetic participants (RR per SD higher FABP4: 0.88 (95% CI: 0.62–1.27), P=0.50), P for diabetes-FABP4 interaction 0.049. In summary, a single measure of plasma FABP4 obtained later in life was not associated with the risk of SCD in older adults overall. Confirmation of our post-hoc results in nondiabetic people in other studies is warranted.http://dx.doi.org/10.1155/2013/181054
spellingShingle Luc Djoussé
Marlena Maziarz
Mary L. Biggs
Joachim H. Ix
Susan J. Zieman
Jorge R. Kizer
Rozenn N. Lemaitre
Dariush Mozaffarian
Russell P. Tracy
Kenneth J. Mukamal
David S. Siscovick
Nona Sotoodehnia
Plasma Fatty Acid Binding Protein 4 and Risk of Sudden Cardiac Death in Older Adults
Cardiology Research and Practice
title Plasma Fatty Acid Binding Protein 4 and Risk of Sudden Cardiac Death in Older Adults
title_full Plasma Fatty Acid Binding Protein 4 and Risk of Sudden Cardiac Death in Older Adults
title_fullStr Plasma Fatty Acid Binding Protein 4 and Risk of Sudden Cardiac Death in Older Adults
title_full_unstemmed Plasma Fatty Acid Binding Protein 4 and Risk of Sudden Cardiac Death in Older Adults
title_short Plasma Fatty Acid Binding Protein 4 and Risk of Sudden Cardiac Death in Older Adults
title_sort plasma fatty acid binding protein 4 and risk of sudden cardiac death in older adults
url http://dx.doi.org/10.1155/2013/181054
work_keys_str_mv AT lucdjousse plasmafattyacidbindingprotein4andriskofsuddencardiacdeathinolderadults
AT marlenamaziarz plasmafattyacidbindingprotein4andriskofsuddencardiacdeathinolderadults
AT marylbiggs plasmafattyacidbindingprotein4andriskofsuddencardiacdeathinolderadults
AT joachimhix plasmafattyacidbindingprotein4andriskofsuddencardiacdeathinolderadults
AT susanjzieman plasmafattyacidbindingprotein4andriskofsuddencardiacdeathinolderadults
AT jorgerkizer plasmafattyacidbindingprotein4andriskofsuddencardiacdeathinolderadults
AT rozennnlemaitre plasmafattyacidbindingprotein4andriskofsuddencardiacdeathinolderadults
AT dariushmozaffarian plasmafattyacidbindingprotein4andriskofsuddencardiacdeathinolderadults
AT russellptracy plasmafattyacidbindingprotein4andriskofsuddencardiacdeathinolderadults
AT kennethjmukamal plasmafattyacidbindingprotein4andriskofsuddencardiacdeathinolderadults
AT davidssiscovick plasmafattyacidbindingprotein4andriskofsuddencardiacdeathinolderadults
AT nonasotoodehnia plasmafattyacidbindingprotein4andriskofsuddencardiacdeathinolderadults